ICYTE PRISM
LIVE

Serial Number

50020040

Owner

IntegriChain, Inc.

Attorney

MATTHEW HOMYK

Filing Date

Jul 29, 2026

Add to watchlist:

No watchlists yet
View on USPTO

ICYTE PRISM Trademark

Serial Number: 50020040

ICYTE PRISM is a trademark filed by IntegriChain, Inc. on July 29, 2026. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

IntegriChain, Inc. (16 trademarks)

100 Canal Pointe Boulevard
Princeton, NJ 08540

Entity Type: 03

Trademark Details

Filing Date

July 29, 2026

Registration Date

Not Registered

Goods & Services

Downloadable computer software using artificial intelligence (AI) for data aggregation, data analytics, data management, data visualization, patient journey analytics, channel analytics, net revenue analytics, commercial data management, market access optimization, drug pricing analysis, rebate management, regulatory compliance monitoring, and data quality stewardship, all for use in the pharmaceutical and life sciences industries; Downloadable computer software for data aggregation, data analytics, data management, data visualization, patient journey analytics, channel analytics, net revenue analytics, commercial data management, market access optimization, drug pricing analysis, rebate management, regulatory compliance monitoring, and data quality stewardship, all for use in the pharmaceutical and life sciences industries

Providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences; Providing an on-line database providing business intelligence in the fields of medical devices, pharmaceuticals and life sciences; Business research and data analysis services in the field of pharmaceutical and life sciences commercial data management, market access optimization, drug pricing analysis, and rebate management; Pharmaceutical cost management services and drug utilization review services

Software as a service (SAAS) services featuring software using artificial intelligence (AI) for data aggregation, data analytics, data management, data visualization, patient journey analytics, channel analytics, net revenue analytics, commercial data management, market access optimization, drug pricing analysis, rebate management, regulatory compliance monitoring, and data quality stewardship, all for use in the pharmaceutical and life sciences industries; Software as a service (SAAS) services featuring software for data aggregation, data analytics, data management, data visualization, patient journey analytics, channel analytics, net revenue analytics, commercial data management, market access optimization, drug pricing analysis, rebate management, regulatory compliance monitoring, and data quality stewardship, all for use in the pharmaceutical and life sciences industries; Platform as a service (PAAS) featuring computer software platforms for data aggregation, data analytics, data management, data visualization, patient journey analytics, channel analytics, net revenue analytics, commercial data management, market access optimization, drug pricing analysis, rebate management, regulatory compliance monitoring, and data quality stewardship, all for use in the pharmaceutical and life sciences industries; Providing on-line non-downloadable software using artificial intelligence (AI) for data aggregation, data analytics, data management, data visualization, patient journey analytics, channel analytics, net revenue analytics, commercial data management, market access optimization, drug pricing analysis, rebate management, regulatory compliance monitoring, and data quality stewardship, all for use in the pharmaceutical and life sciences industries; Providing on-line non-downloadable software for data aggregation, data analytics, data management, data visualization, patient journey analytics, channel analytics, net revenue analytics, commercial data management, market access optimization, drug pricing analysis, rebate management, regulatory compliance monitoring, and data quality stewardship, all for use in the pharmaceutical and life sciences industries

Filing History

APPLICATION FILING RECEIPT MAILED
Jul 29, 2026 MAFR
NEW APPLICATION ENTERED
Jul 29, 2026 NWAP